A股異動 | 博思軟件漲8% 擬斥882.64萬元增資多啦財税
格隆匯12月30日丨博思軟件(300525.SZ)漲8.51%,報20.14元,總市值123億元。博思軟件29日公佈,為滿足公司戰略發展需要,完善公司產業佈局,公司擬使用自有或自籌資金882.64萬元向北京多啦財税科技有限公司增資,認購多啦財税新增註冊資本129.80萬元,增資款中超出其認繳註冊資本的部分計入資本公積。此次增資完成後,公司將持有多啦財税15%股權。多啦財税原股東放棄優先認繳出資權。公吿稱,本次投資完成後,雙方將結合博思公司具備的底層全面數字化的票證能力與多啦財税的大消費領域的場景方案與服務能力,形成數字電子發票及業財票税協同的行業解決方案和SaaS應用。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.